Patch delivers drug, gene, and light-based therapy to tumor sites
Monday, July 25, 2016 - 11:01
in Health & Medicine
Approximately one in 20 people will develop colorectal cancer in their lifetime, making it the third-most prevalent form of the disease in the U.S. In Europe, it is the second-most common form of cancer.